Zosano Pharma Corp Assets, Fair Value Disclosure
Zosano Pharma Corp had Assets, Fair Value Disclosure of $2.08 million as of 2018-03-31, per its 10-Q filed 2018-05-15.
Discontinued › Notes
us-gaap:AssetsFairValueDisclosure · last filed 2018-05-15
- 2018-03-31: Assets, Fair Value Disclosure $2.08M.
- 2017-12-31: Assets, Fair Value Disclosure $650.00K.
- 2017-09-30: Assets, Fair Value Disclosure $9.01M.
- 2017-06-30: Assets, Fair Value Disclosure $15.01M.
| Period end | Assets, Fair Value Disclosure | Assets, Fair Value Disclosure as first filed |
|---|---|---|
| 2018-03-31 | $2.08M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $650.00K 10-Q · filed 2018-05-15 | |
| 2017-09-30 | $9.01M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $15.01M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $5.67M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $11.66M 10-K · filed 2018-03-12 | |
| 2016-09-30 | $11.16M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $19.12M 10-Q · filed 2016-08-10 | |
| 2016-03-31 | $25.07M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $28.90M 10-K · filed 2017-03-01 | $33.97M 10-K · filed 2016-03-29 |
| 2015-09-30 | $40.99M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $46.91M 10-Q · filed 2015-08-13 |